Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
New report calls for more research on women’s health issues
Jul 12, 2024
The National Academies of Sciences, Engineering and Medicine analysis noted that women are disproportionately affected by chronic illnesses, including Alzheimer’s disease, depression and osteoporosis.
Pioglitazone use linked to reduced dementia risk in T2DM
Feb 16, 2023
The reduction in risk was greatest for those with a history of ischemic heart disease or stroke.
Dementia risk score developed in UK Biobank, Whitehall cohorts
Aug 25, 2023
Score had strong discriminatory accuracy in U.K. Biobank test sample and Whitehall cohort, with AUCs of 0.80 and 0.77
Ophthalmic conditions linked to increased risk for dementia
Sep 14, 2021
The risk increased in association with age-related macular degeneration, cataract and diabetes-related eye disease, but not glaucoma.